Abstract Reperfusion results in a rapid reintroduction of oxygen, glucose, and other restricted components to an ischemic tissue. It brings with it not only the necessary components for cell survival but also a burst of oxidative stress and cellular damage. In this study, our primary aims were to investigate glucose as a determining factor for the activation of the transcription factor NF-E2-related factor 2 (Nrf2) upon reperfusion and the expression of downstream anti-oxidant NADPH-dependent reductases. Exposure of renal epithelial HK-2 cells to oxygen and glucose reintroduction after depletion resulted in an increase in nuclear translocation of Nrf2 protein in a manner dependent upon glucose. This activation and the induction of the Nrf2-dependent gene NAD(P)H dehydrogenase, quinone 1 (NQO1) was observed to be maximum at a concentration of 5 mM glucose. Microarray analysis of mRNA from siRNA targeted cells under these conditions revealed the Nrf2-dependent expression of NADPH-dependent reductase enzymes NQO1, Aldo-keto reductase family 1, members C1-3 and dehydrogenase/reductase (SDR family) member 2 (DHRS2), all genes demonstrated to protect against oxidative stress-mediated cellular injury. In addition, NQO1 and DHRS2 mRNA levels were specifically upregulated on glucose reintroduction and were also increased in an in vivo ischemia reperfusion injury model of murine renal pedicle clamping. In conclusion, we demonstrate that glucose reintroduction after depletion activates Nrf2 and Nrf2 regulated NADPH-dependent reductase expression. We suggest these findings represent a previously unreported mechanism for the activation of Nrf2 as a cytoprotective pathway in IRI.
Introduction
The cessation of blood flow to a tissue (Ischemia) causes oxygen and glucose, which are required for normal cellular function, to be restricted. Depending on the severity, duration, and tissue type involved a range of biochemical and signaling alterations occur, which can lead to cell death or to the initiation of adaptive responses to protect the cell until blood flow is restored [1] . Reactive oxidative metabolites including a range of reactive oxygen species (ROS) are generated and accumulate due to mitochondrial and metabolic pathway dysfunction, where they can quickly oxidise and irreversibly damage lipids, proteins, and nucleic acids [2] . If this macromolecular damage is severe enough it triggers apoptosis.
The Nrf2 pathway is one of the main adaptive responses activated under conditions of oxidative stress. Nrf2 is a transcription factor responsible for the induction of phase II detoxification enzymes the primary role of which is to alleviate redox stress [3] . Under normal conditions, Nrf2 is held in the cytoplasm and degraded until sufficient direct oxidative modification of the cysteine residues within its inhibitory binding partner KEAP1 releases it from targeted proteasomal degradation. It then translocates to the nucleus where it dimerises with a small maf protein and directs gene expression at specific anti-oxidant response elements (ARE) within the regulatory regions of responsive genes [3] . Such genes include NADPH-dependent reductase enzymes such as NAD(P)H quinone oxidoreductase NQO1. This enzyme catalyses the reduction of quinones and related molecules preventing their participation in reactions that lead to sulfhydryl depletion or the generation of semiquinones and ROS species through redox cycling [4] . The elimination of these reactive molecules generated in IRI is crucial in preventing oxidative damage and cell ultimately cell death.
Reperfusion following an ischemic event, returning the crucial components carried within the blood to the starved tissue has been perceived as the point at which restoration of normal cellular function should begin. However, it is clear that restoration of these nutrients and substrates brings with it a set of biochemical reactions and responses that lead to further cellular damage [5] . Indeed, many studies have documented not only ischemic-mediated damage and ROS generation but also a reperfusion-specific generation of oxidative stress mediated through ROS [6] . Unsurprisingly, the activation of the Nrf2 pathway has also been observed specifically under reperfusion conditions [7] . However, the characterization of specific components re-introduced on reperfusion and their contribution to oxidative stress and the activation of cytoprotective pathways are incomplete. We have previously demonstrated a role for oxygen reintroduction after ischemia as an independent factor for the generation of oxidative stress and activation of the Nrf2 pathway [7] . In this study, we aim to explore another component of the blood that is reintroduced after ischemia, namely glucose, and what contribution it makes to the activation of Nrf2.
Materials and methods

Cell culture and experimental conditions
Human proximal tubular epithelial HK-2 cells (American Tissue Type Culture Collection, Manassas, VA, USA) were maintained in DMEM/F-12 media containing 5 mM glucose as previously reported [7] . Cells were cultured to confluence before experimental protocols. For treatment, cells were transferred to media containing varying concentrations of glucose [0-15 mM] and were maintained at 37°C in a humidified atmosphere under hypoxic [ 
Renal ischemia reperfusion injury in vivo
Acute renal failure was induced using an established animal model of renal IRI as previously described [8] . Briefly, National Institutes of Health (NIH) Swiss mice (25-35 g ) were subject to renal pedicle clamping for 30 min followed by 24 h reperfusion during recovery. Kidneys were dissected and snap frozen before processing for RNA isolation. This study was approved by the Johns Hopkins University Animal Care and Use Committee.
Nuclear protein isolation and western blot analysis Nuclear extracts were prepared from HK-2 cells as described previously [9] . Protein content was assessed by the Bradford method (Bio-Rad Laboratories, Hertfordshire, UK) and electrophoresed on 10 % SDS PAGE gels. Protein expression levels were measured by western blot analysis using specific antibodies for Nrf2 (Santa Cruz, Heildelberg, Germany), HIF-1a (BD Biosciences, Oxford, UK), and Lamin A/C (Cell Signalling, Beverly MA, USA). Densitometry was performed on scanned autoradiographic film images of developed blots by Image J analysis software (http://rsbweb.nih.gov/ij/).
Real-time quantitative PCR RNA was extracted from tissues and cells by the silica gel column RNeasy extraction method (Qiagen, Crawley, UK) followed by cDNA synthesis as previously reported [7] . Target gene primers for NQO1, Nrf2, DHRS2, and 18S were designed and supplied by the Applied Biosystems (Foster City, CA, USA). Real time PCR was carried out using TaqMan Ò detection reagents (Roche, Branchburg, NJ, USA) using a 7900HT sequence detector and data analyzed with the SDS software package (Applied Biosystems).
Nrf2 siRNA treatment and microarray analysis Before treatment, HK-2 cells were transfected with Nrf2 (20 nM) or non-target random oligonucleotide control (NT, 20 nM) siRNA (Dharmacon, Epsom, UK) for 48 h using Lipofectamine 2000 transfection reagent (Invitrogen, Carlsbad, CA) according to the manufacturer's instructions. RNA from each individual treatment was pooled (n = 3) before cDNA and cRNA synthesis as previously reported [10] . Fragmented cRNA was then hybridized to human U133A 2.0 microarrays (Affymetrix, Santa Clara, CA, USA) and after processing data was analyzed by the Genespring software package (Agilent Technologies, Stockport, UK).
Statistical analysis
All data is presented as mean ± (SEM) for n independent experiments. Statistical significance was evaluated by a two tailed student t test carried out by the InStat software package (GraphPad, San Diego, CA, USA).
Results
Analysis of nuclear Nrf2 protein expression after separation of the components of ischemia and reperfusion
In order to model ischemia, we exposed HK-2 cells to OGD for 8 h followed by reperfusion for up to 16 h. Exposures did not result in cell death (data not shown) allowing us to analyze changes in the Nrf2-signaling pathway, independent of cell injury activated processes. Nuclear Nrf2 accumulation correlates with activation of ARE-dependent promoter activity under ischemia-reperfusion conditions [7] . 8 h of glucose deprivation (0 mM) under normal oxygen caused a slight increase in Nrf2 levels compared to control glucose levels (5 mM) (Fig. 1) . A major finding was that reintroduction of glucose (5 mM) resulted in a significant increase in Nrf2 nuclear accumulation after 2 h (NN -?, Fig. 1 ), which was not observed in control conditions (NN ??, Fig. 1 ). This pattern of increased Nrf2 nuclear protein expression in a condition of glucose reintroduction after depletion was observed under both hypoxia-reoxygenation and sustained hypoxic conditions. This activation was observed to be stronger under hypoxia-reoxygenation conditions (HR -?, Fig. 1 ). We also examined the levels of HIF-1a as it has a major control function on gene expression within ischemic and reperfusion environments. Hypoxia causes an increase in HIF-1a nuclear accumulation after 8-10 h exposure. We also observe that levels of HIF-1a are reduced when glucose is absent from the culture media. There does not appear to be any significant correlation between HIF-1a and Nrf2 levels under the exposed conditions.
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Lamin A/C Nrf2 Fig. 1 Analysis of Nrf2 activation after separating the components of ischemia and reperfusion HK-2 cells were exposed to normoxic (21 % O 2 ) or hypoxic (1 % O 2 ) conditions in the presence (?) or absence (-) of 5 mM glucose for 8 h. Following this incubation, cells were either maintained in normoxic conditions (NN), reoxygenated (HR), or left in sustained hypoxia (HH) for a further 2 h. With this transfer cell culture media was also changed to fresh media. Cells exposed to 8 h ± glucose media had their media replenished with ? glucose media (??). Cells exposed to 8 h minus glucose (-) media had their media changed to both ?glucose media (-?) or -glucose media (--). Nuclear lysates were prepared and levels of Nrf2, HIF1a, and the loading control Lamin A/C were assessed by western blot analysis. Representative blots of three independent experiments are displayed Mol Cell Biochem (2012) 366:231-238 233
Glucose reintroduction after depletion causes Nrf2 accumulation and NQO1 gene expression
In order to examine this Nrf2 response in more detail, we exposed HK-2 cells to a range of glucose concentrations after deprivation. This revealed a statistically significant accumulation of Nrf2, which was maximal when re-introduction of 5 mM glucose for 2 h was carried out. This accumulation was not observed under control conditions ( Fig. 2A) . Analysis of mRNA levels from cells exposed to a range of glucose concentrations on re-introduction for 6 h revealed a significant increase in NQO1 at 2, 5, and 10 mM glucose. This was most significant at 5 mM where there was a 3.67 ± 0.62-fold change in expression compared to baseline 8 h ? glucose levels (Fig. 2B) . The correlation between Nrf2 activation and NQO1 expression was only present at 5 mM glucose reintroduction indicating that nuclear accumulation of Nrf2 is a less sensitive measure of Nrf2 transactivational activity or that other signaling mechanisms potentially contribute to NQO1 induction at other glucose concentrations. Reintroduction of glucose after an initial incubation with glucose as control did not alter NQO1 levels (Fig. 2B) .
Identification of novel Nrf2-dependent gene expression by microarray analysis
We next went on to identify genes altered in IRI, possibly regulated by Nrf2 in a glucose dependent manner. HK-2 cells were transfected with Nrf2 or non-target siRNA before treatment under basal or OGD/reperfusion conditions ( Table 1) . Comparison of gene expression changes in the Nrf2 Knockdown cells compared to NT control siRNA revealed the most highly downregulated gene to be NFE2L2 (Nrf2), thus confirming the specificity and effectiveness of the knockdown. The prototypic Nrf2-dependent gene NQO1 was the second highest downregulated gene followed by genes, which have previously been demonstrated as Nrf2 dependent, aldo-keto reductases, KCNQ2 and PIR. Under basal non-IRI treated conditions there was a significant overlap in the genes downregulated by Nrf2 siRNA. Interestingly, the mitochondrial reductase enzyme DHRS2 (Hep27) was downregulated under both basal and IRI conditions and has not been previously characterized as Nrf2 dependent.
DHRS2 is upregulated by glucose reintroduction after depletion and in an in vivo model of IRI Analysis of mRNA levels from cells exposed to a range of glucose concentrations on re-introduction for 6 h after depletion for 8 h revealed a significant increase in DHRS2 at 2, 5, and 10 mM glucose. The level of increase was similar across all concentrations of re-introduced glucose ranging from 3.16 ± 0.86-fold change in expression at 2 mM to 4.02 ± 1.01-fold change at 10 mM (Fig. 3 ). There were no significant changes in DHRS2 expression when glucose (0-15 mM) was incubated for 6 h after an initial 5 mM glucose exposure for 8 h. Analysis of renal tissue from animals subject to IRI revealed the increased expression of mRNA for Nrf2, NQO1, and DHRS2 (Fig. 4) 
Discussion
In this study, we have attempted to understand in more detail the components of ischemia and reperfusion, which Following this incubation, both conditions were treated with varying concentrations of glucose (0-15 mM) for a further 2 h for nuclear lysate preparation (A) or a further 6 h for mRNA isolation (B). Nuclear lysates were analyzed for levels of Nrf2 and the loading control Lamin A/C by western blot analysis. Densitometry was performed on blots from three independent experiments and results are displayed as an arbitrary densitometric intensity value ±SEM. mRNA was assessed for alterations in the levels of NQO1 by real time PCR analysis. Values were normalized to 18S and results are displayed as mean fold over control 5 mM glucose levels (8 h) ±SEM for four independent experiments. Statistical significance was calculated between ?Glucose and -Glucose groups for each reintroduced glucose concentration and is represented as *p \ 0.05; **p \ 0.01 contribute to redox stress and the activation of the Nrf2 pathway. A substantial amount of work to date has focused on the characterization of ROS generation and oxidative stress within ischemia and many mechanisms such as xanthine oxidase [15] , mitochondria dysfunction [16] , and NADPH oxidase [17] have been suggested as responsible. These same mechanisms are also suggested to generate ROS and oxidative stress on reperfusion and to be major events causing cellular damage [18, 19] . In this study, we demonstrate that Nrf2 and Nrf2-dependent gene expression (NQO1) is activated specifically on glucose reintroduction after depletion, and suggest this change in glucose as a contributory mechanism through which reperfusion can initiate the activation of this cytoprotective pathway. Whether glucose reintroduction is also a trigger for oxidative stress is an important point to consider. Importantly, our study builds on previous work where we have demonstrated reintroduction of oxygen after deprivation as a contributory factor to reperfusion specific activation of Nrf2 [7] . Fig. 3 Glucose reintroduction after deprivation induces the expression of the reductase enzyme DHRS2. HK-2 cells under normal oxygen concentration (21 % O 2 ) were incubated for 8 h in the presence or absence of 5 mM glucose. Following this incubation, both conditions were treated with varying concentrations of glucose (0-15 mM) for a further 6 h. mRNA was isolated and assessed for alterations in the levels of DHRS2 by real time PCR analysis. Values were normalized to 18S and results are displayed as mean fold over control 5 mM glucose levels (8 h) ±SEM for four independent experiments. Statistical significance was calculated between ?Glucose and -Glucose groups for each reintroduced glucose concentration and is represented as *p \ 0.05
The observation that glucose re-introduction on reperfusion can generate ROS has been explored previously. Neuronal cultures exposed to oxygen and glucose deprivation (OGD) for 2 h followed by reintroduction, demonstrated superoxide production and lipid peroxidation only when glucose was present in the reperfusate [20] . Interestingly, a physiologically normal concentration of glucose was used in this and our own study. NADPH oxidase was identified in this and another study [15] as the primary mechanism through which oxidative stress was generated by glucose re-introduction. It was also suggested that shunting of glucose through the pentose phosphate pathway, thus generating NADPH used for superoxide production by NADPH oxidase. Interestingly, a shift toward the pentose phosphate pathway has been observed during the recovery phase of ischemia in astrocytes [21] . Glucose-6-phosphate dehydrogenase (G6PD), the rate-limiting enzyme in the pentose phosphate pathway is upregulated in our models of in vitro and in vivo IRI and also downregulated by Nrf2 siRNA in our study (data not shown). Also, mice lacking G6PD have poorer cardiac function and decreased GSH upon reperfusion only and not during ischemia [22] . It is therefore interesting to speculate whether similar signaling pathways are activated in our model systems leading to the activation of Nrf2.
This study is the first to demonstrate the activation of Nrf2 and NQO1 upon reintroduction of physiological levels of glucose after deprivation. Many studies, however, have observed that increasing the levels of glucose above 8 mM, considered hyperglycemic [23] results in the generation of ROS and the activation of Nrf2 [24] . Indeed, many mechanisms have been postulated as to how ROS are generated in elevated glucose conditions with NADPH oxidase likely a major player [25] . With increasing evidence that the pentose phosphate pathway plays a role in hyperglycemia induced ROS generation through NADPH oxidase [26] and that Nrf2 and ischemia reperfusion can upregulate genes involved in the pentose phosphate pathway [27] it is important to consider whether common pathways exist for the generation and adaptation to oxidative stress between conditions of elevated glucose and those that involve glucose reintroduction after ischemia.
siRNA targeting and microarray analysis identified a number of genes, including NQO1 as Nrf2 dependent. NQO1 acts to reduce quinones and related molecules and in doing so along with other NADPH-dependent enzymes with different specificities not only reduce oxidative stress within the cell but also control the levels of NADPH. Importantly, NQO1 KO mice display increased levels of NADPH and altered redox balance [28] . Another set of NADPH-dependent oxidoreductases identified as downregulated by Nrf2 siRNA were the aldo-keto reductases (AKR1C1-AKR1C3). These genes have different substrate specificity as compared to NQO1 and target steroid hormones, prostaglandins, and xenobiotics among others. Like NQO1, these genes have been previously demonstrated as Nrf2 dependent [12] and to be protective in oxidative stress conditions. However, another NADPH-dependent reductase enzyme identified in our Nrf2 siRNA screen, DHRS2 (Hep27) has not been previously demonstrated as Nrf2 dependent or responsive to glucose reintroduction after depletion. This gene is a member of the short-chain dehydrogenase/reductase (SDR) family of reductases with a known specificity for reactive dicarbonyl compounds [29] . These compounds are generated during the course of metabolic processes or oxidative stress and have been suggested to originate from carbohydrates such as glucose and lipids, which undergo non-enzymatic Maillard reactions ultimately leading to the production of advanced glycation end products (AGEs) [30] . It is therefore likely that the specific induction of DHRS2 upon glucose reintroduction functions to inactivate dicarbonyl compounds produced as a consequence of altered metabolic and oxidative handling of reintroduced glucose after an ischemic or deprivation event. Indeed, the functional activity of DHRS2 in alleviating oxidative stress and associated damage has been demonstrated using specific siRNA [31] . Given that we have identified this gene for the first time as upregulated in an in vivo model of IRI we would speculate it has a similar contribution to protection against oxidative stress in IRI conditions. It is also important to note that the DHRS2 pattern of expression on glucose reintroduction did not exactly reflect the profile of Nrf2 in our system and may indicate the contribution of other signaling pathways in its regulation. Indeed, there are many signaling pathways activated in ischemia reperfusion, which can be causative of or activated in response to oxidative stress. Such pathways may integrate Nrf2 signaling and include modulators of inflammatory cells and cascades, NF-kB, IL-6, IL-10, IL-17, the NLRP3 inflammasome and toll like receptors (TLR) [32, 33] . Interestingly, an endogenous ligand of TLR4, biglycan is attenuated by Nrf2 siRNA in our model ( Table 1 ). The hypoxia-induced factor (HIF) pathway is also a significant regulator of gene expression in IRI. It is important for inflammatory gene regulation, tissue survival, and injury resolution through mechanisms including increased adenosine production [32] [33] [34] . From our microarray data we observe an increase in CD79 and ADORA1 (key components of extracellular adenosine generation and signaling) expression on reintroduction of glucose and oxygen after deprivation (Data not shown). These genes were not altered with Nrf2 siRNA treatment but as Nrf2 has been previously observed as activated by increased extracellular adenosine [35] it is possible such interactions may exist in our model. The involvement of HIF-1a in this glucose-triggered control of Nrf2 pathway activation is unclear at this time as we did not observe any significant correlation between levels of these two transcription factors.
In summary, we have demonstrated the upregulation of the anti-oxidant transcription factor Nrf2 and Nrf2-dependent NADPH reductase enzymes upon glucose reintroduction after deprivation and suggest that glucose level changes upon reperfusion as a possible contributory mechanism for activation of this pathway in IRI.
